HomeJohnson & Johnson

Johnson & Johnson

Pfizer Sets Eyes On $10 billion+ Opportunity For RSV Vaccines

August 29, 2022

Johnson & Johnson attempts to extend its “Texas two-step” in order to end talc litigation in two states

August 22, 2022

Johnson & Johnson Stock Might Be A Good Buy Before Its Upcoming Earnings Release

Johnson & Johnson Stock Might Be A Good Buy Before Its Upcoming Earnings Release

July 18, 2022

« 1 2 3